Page 1 | Search Results | Diabetes | American Diabetes Association

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G

Shafeeq A. Mohammed, PhD, Era Gorica, PhD, Mattia Albiero, PhD, Gergely Karsai, PhD, Alessandro Mengozzi, MD, PhD, Carlo Maria Caravaggi, MD, Samuele Ambrosini, PhD, Stefano Masi, MD, PhD, Maria Cristina Vinci, PhD, Omer Dzemali, Gaia Spinetti, PhD, Sanjay Rajagopalan, MD, Assam El-Osta, PhD, Jaroslav Pelisek, Frank Ruschitzka, MD, Gian Paolo Fadini, MD, PhD, Sarah Costantino, PhD, Francesco Paneni, MD, PhD

Diabetes db240997

https://doi.org/10.2337/db24-0997

Published: 27 February 2025

View article titled, Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G

Journal Articles

Padi4-dependent NETosis enables diet-induced gut hyperpermeability, translating dysbiosis into systemic inflammation and dysmetabolism

Diabetes db240481

https://doi.org/10.2337/db24-0481

Published: 13 February 2025

View article titled, Padi4-dependent NETosis enables diet-induced gut hyperpermeability, translating dysbiosis into systemic inflammation and dysmetabolism

Journal Articles

Loss of Hematopoietic Cell–Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice

Mattia Albiero, Stefano Ciciliot, Anna Rodella, Ludovica Migliozzi, Francesco Ivan Amendolagine, Carlotta Boscaro, Gaia Zuccolotto, Antonio Rosato, Gian Paolo Fadini

Diabetes 2023;72(4):483–495

https://doi.org/10.2337/db22-0054

Published: 19 January 2023

View article titled, Loss of Hematopoietic Cell–Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice

Journal Articles

Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19

Benedetta Maria Bonora, Paola Fogar, Jenny Zuin, Daniele Falaguasta, Roberta Cappellari, Annamaria Cattelan, Serena Marinello, Anna Ferrari, Angelo Avogaro, Mario Plebani, Daniela Basso, Gian Paolo Fadini

Diabetes 2022;71(4):788–794

https://doi.org/10.2337/db21-0965

Published: 21 January 2022

View article titled, Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19

Meeting Abstracts

109-LB: Comparative Effectiveness of Insulin Glargine 300 U/mL (Gla-300) and Insulin Degludec 100 U/mL (iDeg-100) in Insulin-Naïve Type 2 Diabetes Adults: RESTORE-2 Real-World Study

GIAN PAOLO FADINI, RAFFAELLA BUZZETTI, ANTONIO NICOLUCCI, MARIA CHIARA ROSSI, MONICA LAROSA, DOMENICO CUCINOTTA, ON BEHALF OF RESTORE-2 STUDY GROUP

Diabetes 2021;70(Supplement_1):109-LB

https://doi.org/10.2337/db21-109-LB

Published: 01 June 2021

View article titled, 109-LB: Comparative Effectiveness of Insulin Glargine 300 U/mL (Gla-300) and Insulin Degludec 100 U/mL (iDeg-100) in Insulin-Naïve Type 2 Diabetes Adults: RESTORE-2 Real-World Study

Journal Articles

Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and Ketogenesis

Mattia Albiero, Serena Tedesco, Francesco Ivan Amendolagine, Marianna D’Anna, Ludovica Migliozzi, Gaia Zuccolotto, Antonio Rosato, Roberta Cappellari, Angelo Avogaro, Gian Paolo Fadini

Diabetes 2021;70(8):1767–1779

https://doi.org/10.2337/db20-1045

Published: 26 April 2021

View article titled, Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and Ketogenesis

Journal Articles

Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes

Serena Tedesco, Stefano Ciciliot, Lisa Menegazzo, Marianna D’Anna, Valentina Scattolini, Roberta Cappellari, Andrea Cignarella, Angelo Avogaro, Mattia Albiero, Gian Paolo Fadini

Diabetes 2020;69(7):1562–1572

https://doi.org/10.2337/db19-0640

Published: 28 April 2020

View article titled, Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes

Meeting Abstracts

375-P: Switching to Insulin Degludec from Other Basal Insulins Reduces Rates of Hypoglycemia across Patient Subgroups in Routine Clinical Care: The ReFLeCT Study

HAROLD W. DE VALK, MICHAEL FEHER, TROELS K. HANSEN, JOHAN H. JENDLE, ÁNGEL MERCHANTE, METTE M. KOEFOED, EHSAN PARVARESH RIZI, ESTHER ZIMMERMANN, GIAN PAOLO FADINI

Diabetes 2019;68(Supplement_1):375-P

https://doi.org/10.2337/db19-375-P

Published: 01 June 2019

View article titled, 375-P: Switching to Insulin Degludec from Other Basal Insulins Reduces Rates of Hypoglycemia across Patient Subgroups in Routine Clinical Care: The ReFLeCT Study

Meeting Abstracts

374-P: Reduced Rates of Hypoglycemia Irrespective of the Definition Used When Switching to Insulin Degludec (degludec) from Other Basal Insulins in Routine Clinical Care: The ReFLeCT Study

HAROLD W., DE VALK, MICHAEL FEHER, TROELS K. HANSEN, JOHAN H. JENDLE, ÁNGEL MERCHANTE, METTE M. KOEFOED, EHSAN PARVARESH RIZI, ESTHER ZIMMERMANN, GIAN PAOLO FADINI

Diabetes 2019;68(Supplement_1):374-P

https://doi.org/10.2337/db19-374-P

Published: 01 June 2019

View article titled, 374-P: Reduced Rates of Hypoglycemia Irrespective of the Definition Used When Switching to Insulin Degludec (degludec) from Other Basal Insulins in Routine Clinical Care: The ReFLeCT Study

Journal Articles

Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway

Mattia Albiero, Stefano Ciciliot, Serena Tedesco, Lisa Menegazzo, Marianna D’Anna, Valentina Scattolini, Roberta Cappellari, Gaia Zuccolotto, Antonio Rosato, Andrea Cignarella, Marco Giorgio, Angelo Avogaro, Gian Paolo Fadini

Diabetes 2019;68(6):1303–1314

https://doi.org/10.2337/db19-0080

Published: 01 April 2019

View article titled, Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway

Includes: Supplementary data

Journal Articles

NETosis Delays Diabetic Wound Healing in Mice and Humans

Gian Paolo Fadini, Lisa Menegazzo, Mauro Rigato, Valentina Scattolini, Nicol Poncina, Andrea Bruttocao, Stefano Ciciliot, Fabio Mammano, Catalin Dacian Ciubotaru, Enrico Brocco, Maria Cristina Marescotti, Roberta Cappellari, Giorgio Arrigoni, Renato Millioni, Saula Vigili de Kreutzenberg, Mattia Albiero, Angelo Avogaro

Diabetes 2016;65(4):1061–1071

https://doi.org/10.2337/db15-0863

Published: 06 January 2016

View article titled, NETosis Delays Diabetic Wound Healing in Mice and Humans

Includes: Multimedia, Supplementary data

Journal Articles

Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M

Mattia Albiero, Nicol Poncina, Stefano Ciciliot, Roberta Cappellari, Lisa Menegazzo, Francesca Ferraro, Chiara Bolego, Andrea Cignarella, Angelo Avogaro, Gian Paolo Fadini

Diabetes 2015;64(8):2957–2968

https://doi.org/10.2337/db14-1473

Published: 24 March 2015

View article titled, Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M

Includes: Supplementary data

Journal Articles

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor

Gian Paolo Fadini, Mark Fiala, Roberta Cappellari, Marianna Danna, Soo Park, Nicol Poncina, Lisa Menegazzo, Mattia Albiero, John DiPersio, Keith Stockerl-Goldstein, Angelo Avogaro

Diabetes 2015;64(8):2969–2977

https://doi.org/10.2337/db15-0077

Published: 24 March 2015

View article titled, Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor

Includes: Supplementary data

Journal Articles

Diabetes Causes Bone Marrow Autonomic Neuropathy and Impairs Stem Cell Mobilization via Dysregulated p66Shc and Sirt1

Mattia Albiero, Nicol Poncina, Marc Tjwa, Stefano Ciciliot, Lisa Menegazzo, Giulio Ceolotto, Saula Vigili de Kreutzenberg, Rute Moura, Marco Giorgio, Piergiuseppe Pelicci, Angelo Avogaro, Gian Paolo Fadini

Diabetes 2014;63(4):1353–1365

https://doi.org/10.2337/db13-0894

Published: 13 March 2014

View article titled, Diabetes Causes Bone Marrow Autonomic Neuropathy and Impairs Stem Cell Mobilization via Dysregulated <em>p66Shc</em> and <em>Sirt1</em>

Includes: Supplementary data

Journal Articles

The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing

Gian Paolo Fadini, Mattia Albiero, Lisa Menegazzo, Elisa Boscaro, Elisa Pagnin, Elisabetta Iori, Chiara Cosma, Annunziata Lapolla, Vittorio Pengo, Massimo Stendardo, Carlo Agostini, Pier Giuseppe Pelicci, Marco Giorgio, Angelo Avogaro

Diabetes 2010;59(9):2306–2314

https://doi.org/10.2337/db09-1727

Published: 21 June 2010

View article titled, The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing

Includes: Supplementary data

Journal Articles

Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms

Saula Vigili de Kreutzenberg, Giulio Ceolotto, Italia Papparella, Alessia Bortoluzzi, Andrea Semplicini, Chiara Dalla Man, Claudio Cobelli, Gian Paolo Fadini, Angelo Avogaro

Diabetes 2010;59(4):1006–1015

https://doi.org/10.2337/db09-1187

Published: 12 January 2010

View article titled, Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms

Includes: Supplementary data

NARROW

Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G

Padi4-dependent NETosis enables diet-induced gut hyperpermeability, translating dysbiosis into systemic inflammation and dysmetabolism

Loss of Hematopoietic Cell–Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice

Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19

109-LB: Comparative Effectiveness of Insulin Glargine 300 U/mL (Gla-300) and Insulin Degludec 100 U/mL (iDeg-100) in Insulin-Naïve Type 2 Diabetes Adults: RESTORE-2 Real-World Study

Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and Ketogenesis

Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes

375-P: Switching to Insulin Degludec from Other Basal Insulins Reduces Rates of Hypoglycemia across Patient Subgroups in Routine Clinical Care: The ReFLeCT Study

374-P: Reduced Rates of Hypoglycemia Irrespective of the Definition Used When Switching to Insulin Degludec (degludec) from Other Basal Insulins in Routine Clinical Care: The ReFLeCT Study

Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway

NETosis Delays Diabetic Wound Healing in Mice and Humans

Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor

Diabetes Causes Bone Marrow Autonomic Neuropathy and Impairs Stem Cell Mobilization via Dysregulated p66Shc and Sirt1

The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing

Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only